243 results
Page 2 of 13
8-K
EX-99.1
oyopgrq9l0b6f t4x
11 Aug 22
Acasti Pharma Reports First Quarter 2023 Operational Results
7:05am
8-K
EX-99..1
zifnbmfjvno3ozh6bz
21 Jun 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
hpo5yel5y nc7kzf
18 May 22
Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, with Intravenous GTX-104 Meeting All Endpoints
7:37am
8-K
EX-99.1
8j7gel5 rft5d
25 Mar 22
Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors
7:36am
8-K
EX-99.1
duvkp5hbrr9 muit8b
14 Feb 22
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022
7:10am
8-K
EX-99.1
rlx92 xas1oxbr
2 Dec 21
Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104
7:17am
8-K
EX-99.1
4hp1fwg3mpw392v1
15 Nov 21
Acasti Pharma Announces Annual Stock Option Grants
12:00am
8-K
EX-99.1
jtlsuybavsw6c9wm00
10 Nov 21
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022
7:09am
8-K
EX-99.1
teze le71a7w
22 Sep 21
Acasti Pharma Provides Update Following Acquisition of Grace Therapeutics and Regains Compliance with Nasdaq Listing Standards
8:30am
8-K
EX-99.2
06a8 mp7wv
27 Aug 21
Completion of Acquisition or Disposition of Assets
8:47am
425
EX-99.1
cuupybh
12 Aug 21
Business combination disclosure
11:00am
8-K
EX-99.1
l1dj9sly3
12 Aug 21
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022
10:57am
8-K
EX-99.1
y87 vt1kudrjqwpx5i
23 Jul 21
Other Events
8:43am
425
EX-99.1
zgqjw088e 9ooa
23 Jul 21
Business combination disclosure
8:41am
424B3
b2wcrh
15 Jul 21
Prospectus supplement
4:45pm
S-4/A
9la9d6zreer
13 Jul 21
Registration of securities issued in business combination transactions (amended)
4:41pm